Details checkedClinical trial listing onlyCheckedregistry

AP-HP APLOSIA bilateral Cochlear Osia pediatric study

Also known as: APLOSIA, OSIA System bilateral implantation, Bilateral OSIA2 implantation, Cochlear Osia, NCT07358728

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Device

Modality

Cochlear/Auditory Implant

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Bilateral implantable bone-conduction hearing system

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

France

Population

pediatric, conductive, bilateral, bone-conduction, microtia, ear-atresia

Trial IDs

Mechanism

Not-yet-recruiting AP-HP study evaluating bilateral Cochlear Osia/OSIA2 active transcutaneous bone-conduction implantation in children with high-grade microtia or ear atresia, including unilateral-versus-bilateral activation comparisons.

Indications

Hearing Loss Conductive Hearing Loss

Notes

Corrected from a generic audiological-tests fragment to the APLOSIA pediatric bilateral Osia implantation study. The registry describes a clinical study of bilateral OSIA2 implantation and audiological outcomes, not a standalone diagnostic test product. Cochlear is listed as product manufacturer/context, while the trial sponsor remains AP-HP.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT07358728

Open

Key Events

2026-01-22

ClinicalTrials.gov first posted APLOSIA

2026-02-13

ClinicalTrials.gov posted latest APLOSIA update reviewed in this pass

Clinical Trials (1)